Canopy Growth Corp (CGC) stock
CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.50−0.03 (-5.63%)
Close on Nov 18, 2026Market cap $212.15MP/E –Yield –
Canopy Growth revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Canopy Growth's revenue for the twelve months ending Jun 30, 2026 was C$293.63M, up 6.8% year over year. For fiscal 2026 it was C$284.60M, up 5.8% from the year before. The highest annual figure on record is C$546.65M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | C$284.60M | +5.8% |
| FY2025 | Mar 31, 2025 | C$269.00M | -9.5% |
| FY2024 | Mar 31, 2024 | C$297.15M | -10.8% |
| FY2023 | Mar 31, 2023 | C$333.25M | -29.9% |
| FY2022 | Mar 31, 2022 | C$475.70M | -13.0% |
| FY2021 | Mar 31, 2021 | C$546.65M | +37.1% |
| FY2020 | Mar 31, 2020 | C$398.77M | +76.2% |
| FY2019 | Mar 31, 2019 | C$226.34M | +190.4% |
| FY2018 | Mar 31, 2018 | C$77.95M | +95.4% |
| FY2017 | Mar 31, 2017 | C$39.90M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | C$81.17M | +12.5% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | C$71.25M | +9.6% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | C$74.54M | -0.3% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | C$66.68M | +5.9% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | C$72.13M | +8.9% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | C$65.03M | -10.7% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | C$74.76M | -4.8% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | C$62.99M | -9.5% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | C$66.21M | -13.2% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | C$72.79M | +6.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | C$78.51M | -7.5% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | C$69.60M | -20.9% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | C$76.26M | -28.0% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | C$68.24M | +1.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | C$84.85M | -39.8% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | C$87.94M | -33.1% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | C$105.92M | -22.2% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | C$67.14M | -54.8% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | C$140.97M | -7.6% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | C$131.37M | -2.9% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | C$136.21M | +23.4% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | C$148.44M | +37.6% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | C$152.53M | +23.2% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | C$135.27M | +76.6% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | C$110.42M | +22.0% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | C$107.91M | +14.7% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | C$123.76M | +49.0% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | C$76.61M | +228.4% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | C$90.48M | +249.1% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | C$94.05M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | C$83.05M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | C$23.33M | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | C$25.92M | – |
See a number that looks wrong?